The cell of origin of hepatoblastoma in humans and mice is unknown; it is hypothesized to be a transformed hepatocyte, oval cell, or hepatic progenitor cell. In mice, current dogma is that hepatoblastomas arise from pre-existing hepatocellular neoplasms as a result of further neoplastic transformation. However, there is little evidence supporting this direct relationship. To better understand the relationship between hepatocellular carcinoma (HCC) and hepatoblastoma, and determine molecular similarities between mouse and human hepatoblastoma, global gene expression analysis and targeted mutation analysis were performed using hepatoblastoma, HCC, and adjacent liver from the same animals in a recent National Toxicology Program bioassay. There were significant differences in Hras and Ctnnb1 mutation spectra, and by microarray, hepatoblastomas showed dysregulation of embryonic development, stem cell pluripotency, and genomic imprinting compared to HCC. Meta-analysis showed similarities between hepatoblastoma, early mouse embryonic liver, and hepatocyte derived stem/progenitor cells compared to HCC. Our data shows that there are striking differences between hepatoblastoma and HCC, and suggests that hepatoblastoma is a significantly different entity that may arise from a hepatic precursor cell. Furthermore, mouse hepatoblastoma is similar to the human disease at the pathway level, and therefore is likely a relevant model for evaluating human cancer hazard.